Since we have previously shown that PAR activation plays a pivotal role in extracellular-regulated kinase (ERK1/2)-induced activity in colon cancer [7,8,9], we next investigated the effect of KLK6 on ERK1/2 phosphorylation in HT-29 cells. Here, MAPK3 is linked to malignant colon neoplasm.